Hinge Health (HNGE) Insider Group Sells $16M of Stock
LLC Insight Holdings Group sold shares of Hinge Health, Inc. for approximately $15.92 million.
Reviewed by automated data checks against the source filing. How we make and check alerts
LLC Insight Holdings Group sold 224,399 shares of Hinge Health, Inc. ($HNGE) at an average price of $70.96, worth about $15.92 million, on June 22, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $HNGE is up 18.3% after 1 week, up 14.9% after 1 month and up 44.0% to date (from the $68.85 close on Jun 22, 2026).
Key Points
- LLC Insight Holdings Group sold 224,399 shares of Hinge Health, Inc. for about $15.92 million on June 22, 2026.
- Hinge Health shares are currently trading at $70.56, down from a previous close of $105.00.
- Analysts maintain a consensus rating of 'buy' with a mean price target of $112.13.
Get $HNGE trade alerts by text
We text you when insiders, Congress or big funds trade $HNGE. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Hinge Health, Inc. alert may contain errors. Disclosures
Insight Holdings Group's Recent Sale
On June 22, 2026, LLC Insight Holdings Group sold 224,399 shares of Hinge Health, Inc. (NYSE: HNGE) for approximately $15.92 million. The shares were sold at an average price of $70.96 each. This transaction was part of a planned selling strategy by the group.
Changes in Position
This recent sale reduced LLC Insight Holdings Group's stake in Hinge Health. After this transaction, the group holds 530,982 shares. The sale reflects a continuation of their trading activity, which has included both purchases and sales in the past weeks.
Institutional Activity
No other institutional investors reported changes to their positions in Hinge Health during this period, as there are no peer funds listed in the data.
How Hinge Health, Inc. Stock Has Traded
Hinge Health shares are currently priced at $70.56, significantly lower than their 52-week high of $107.00. The stock has experienced a decline from its previous close of $105.00. This drop may have influenced the decision by LLC Insight Holdings Group to sell a portion of its holdings.
Recent Earnings
Hinge Health reported revenue of $720.06 million with a revenue growth rate of 53% and an earnings per share (EPS) of $3.03. The company has a net margin of about 15% and a return on equity (ROE) of 30.38%. The next earnings report is scheduled for November 2, 2026.
Insider Buying and Selling at Hinge Health, Inc.
In addition to this sale, LLC Insight Holdings Group has been active in trading Hinge Health shares. On June 23, 2026, they sold another 112,477 shares for about $7.90 million at an average price of $70.21. Earlier, on June 29, they purchased 1,466,667 shares, showing a mix of buying and selling in their strategy.
Analysts Set New Price Targets
Analysts have a generally favorable view of Hinge Health. On October 16, 2026, Keybanc maintained an Overweight rating with a price target of $140. Barclays also maintained an Overweight rating with a target of $110 on October 12, 2026. The consensus rating among analysts remains a 'buy' with a mean price target of $112.13.
What Hinge Health, Inc. Does
Hinge Health, Inc. focuses on providing technology-driven healthcare solutions, particularly in musculoskeletal care. The company serves self-insured employers and aims to enhance the delivery of care through innovative platforms. This insider sale may indicate a strategic shift in investment by LLC Insight Holdings Group as they manage their stake in the company.
What to Watch at Hinge Health, Inc.
Investors should keep an eye on the upcoming earnings report on November 2, 2026, as well as any further trading activity from LLC Insight Holdings Group. This recent sale reflects past holdings as of the reporting date and may not represent current positions.
Source: LLC Insight Holdings Group's Form 4 filing on $HNGE (Jun 22, 2026). Find the original filing: HNGE Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
